Humana (HUM) stock jumps as the company with its Q2 results lifts its 2025 outlook, citing strength in its Medicare Advantage ...

Key Takeaways Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than ...

Humana's Q2 2025 earnings showcase raised EPS guidance, driven by CenterWell Pharmacy outperformance and MA membership gains.

Humana lowered its full-year 2025 GAAP EPS guidance to approximately $13.77, down from $14.68. At the same time, it raised ...

Humana Wednesday reported $545 million in second quarter profits as the health insurer’s medical cost trends fell in line ...

Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher ...

The Kentucky-based company’s results are a bright spot in what’s otherwise been a gloomy quarter for health insurers. Humana ...

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

Humana, the Louisville-based health insurance company, reported a "solid performance" in the second quarter of this year.

Humana Inc. (NYSE: HUM) touted “solid” second-quarter results and emphasized a multi-year transformation centered on scalable growth, cost reduction and ...

Humana beat Q2 EPS and revenue estimates and raised its 2025 outlook, driven by strong PDP growth and higher CenterWell ...

The S&P 500 fell 0.1% on Wednesday, July 30, 2025, as the Fed held interest rates steady and policymakers expressed concerns ...